A high intake of menaquinones (vitamin K2) was associated with a reduced risk of coronary heart disease, at least in hypertensive participants, while high intake of phylloquinone (vitamin K1) was not associated with any reduced risks, according to a study published in Clinical Nutrition.###“As withzinc gluconate cream the Rotterdam Study (2004) and Prospect-EPIC Study (2009), a link has been established between intake of long-chain menaquinones and cardiovascular health,” says Hogne Vik, chief medical officer with Nattofergon iron supplement 325 mgPharma. ###“Improving one’s K2 status results in less calcification of the arteries and soft tissues, leading to improved long-term health outcomes.”###“These benefits are recognized with Vitamin K2, but not K1, which is important because there is a misconception that daily recommended intake (RDI) of the vitamin K1 is sufficient to protect the arteries for developing arterial diseases.”###“This is not the case, since vitamin K1 is only documented and recognized to meet our needs for coagulation.” ###“It is, however, vitamin K2, the menaquinones, that are responsible for the cardiovascular benefits, and not vitamimagnesium citrate fred meyern K1,” adds Vik.###This prospbest quality calcium citrate supplementective cohort study included 33,289 participants from the EPIC-NL cohort, aged 20-70 years at baseline and reccitomag medicineruited between 1993 and 1997. ###Dietary intake was assessed at baseline with a validated food frequency questionnaire and intakes of phylloquinone, and total, short-chain and long-chain menaquinones were calculated.